CCN2 and metabolic dysfunction-associated steatotic liver disease: We initially expected that because CTGF is a crucial factor in liver fibrosis and its serum level has been reported as a marker of fibrosis [9], its level should be associated with the progression of liver fibrosis in patients with NAFLD.